Recurrent CVA with Hyponatremia

Overview

Why Hyponatremia Occurs in CVA (Pathophysiology)

1. SIADH (Syndrome of Inappropriate ADH Secretion) - Most Common

• Common triggers: stress, pain, nausea, anxiety, and neurological injury itself
• Results in: euvolemic hypotonic hyponatremia, urine sodium >20 mEq/L, urine osmolality >100 mOsm/kg

2. Cerebral Salt Wasting (CSW) - Especially in SAH

• Critical distinction from SIADH: CSW is hypovolemic, while SIADH is euvolemic
• Treating CSW with free-water restriction (appropriate for SIADH) is dangerous - it worsens volume depletion and increases stroke risk
• Correct with isotonic or hypertonic saline + fludrocortisone

3. Comorbidity-Driven Hyponatremia

• Heart failure (16% vs 12% in normonatremic stroke patients)
• Diabetes mellitus (68% vs 35%)
• Chronic kidney disease (19% vs 9%)
• Thiazide diuretics use (29% vs 20%)
• Liver disease (9% vs 2%)

4. Drug-Related Causes

• Thiazide diuretics (very common in hypertensive patients who have strokes)
• SSRIs/SNRIs (used post-stroke for depression or pain)
• Antiepileptics (carbamazepine, oxcarbazepine) - particularly relevant if post-stroke seizures occur
• NSAIDs

5. Hypothalamic-Pituitary Dysfunction

How Hyponatremia Contributes to Recurrent CVA

Direct Mechanisms

• Cerebral edema from hypotonicity worsens vasospasm and ischemia
• In SAH: hyponatremia-induced volume depletion reduces cerebral perfusion pressure, triggering delayed cerebral ischemia - one of the four major causes of delayed neurologic deterioration in SAH (along with rerupture, hydrocephalus, and vasospasm)
• Seizure threshold lowering: hyponatremia lowers seizure threshold; post-ictal Todd's paralysis can mimic CVA, and true seizures worsen neurological injury

Stroke Mimic vs. Real Recurrence

Outcome Data (2024)

• Hyponatremia at admission: 14% of patients
• Associated with worse 3-month mRS score (acOR = 1.76, 95% CI 1.12-2.76)
• Associated with increased in-hospital mortality (aOR = 2.39, 95% CI 1.23-4.67)
• Associated with a larger infarct core and higher core-to-penumbra ratio - suggesting worse tissue fate even before treatment

Diagnostic Approach in a Recurrent CVA Patient with Hyponatremia

Step 1 - Confirm true hyponatremia

• Rule out pseudohyponatremia (hyperlipidemia, hyperproteinemia) - check serum osmolality
• Rule out hypertonic hyponatremia (hyperglycemia, mannitol)

Step 2 - Assess volume status clinically

Step 3 - Investigations

• Serum: Na+, K+, osmolality, glucose, urea, creatinine, TFTs, 8am cortisol
• Urine: Na+, osmolality (spot)
• Imaging: CT/MRI brain to confirm new infarct vs. mimic

Step 4 - SIADH vs. CSW (the critical distinction post-stroke)

Management

Acute Symptomatic Hyponatremia (seizures, obtundation)

• 3% hypertonic saline: 100-150 mL IV over 10-20 minutes, can repeat 2-3 times until symptoms resolve
• Target: raise Na+ by 5 mmol/L acutely to control symptoms

Correction Rate (to avoid osmotic demyelination syndrome, ODS)

• High-risk patients (malnutrition, alcoholism, liver disease, K+ depletion): do not exceed 4-6 mmol/L/day
• Low-risk patients: maximum 10-12 mmol/L in any 24 hours or 18 mmol/L in 48 hours
• Never exceed 10-12 mmol/L/day in any patient

Specific Management by Cause

• Mild/chronic: fluid restriction (800-1000 mL/day) + treat underlying cause
• Moderate-severe or symptomatic: hypertonic saline, consider vaptan (tolvaptan) for euvolemic chronic SIADH
• Avoid free-water-containing IV fluids

• Volume replacement is the cornerstone - normal or hypertonic saline
• Fludrocortisone 0.1-0.2 mg BD helps reduce urinary sodium loss
• Do NOT restrict fluids - this is dangerous in SAH patients

• Stop the thiazide; switch to an alternative antihypertensive
• Correct volume and sodium

Special Considerations for Recurrent CVA

1. Do not assume a new focal deficit is a structural recurrence - check sodium first. A drop to Na+ ~125 mEq/L can produce focal mimics.
2. SAH patients: hyponatremia is particularly dangerous because treatment with fluid restriction (used in SIADH) can precipitate vasospasm and new ischemic stroke. Always distinguish SIADH from CSW.
3. Medications audit at every admission: many stroke patients take thiazides (antihypertensive), SSRIs (depression, neuropathic pain), and antiepileptics - all of which lower sodium.
4. Seizure workup: new hyponatremia + focal deficit may represent a seizure with post-ictal Todd's paralysis, not true CVA recurrence - EEG and sodium correction are both needed.
5. Neurovascular surveillance: in euvolemic SIADH after stroke, fluid restriction is appropriate but must be balanced against the need for adequate perfusion pressure in borderzone/watershed territories, especially in large-vessel atherosclerotic disease.

Summary